In:
Pharmacia, Pensoft Publishers, Vol. 68, No. 3 ( 2021-09-15), p. 713-720
Abstract:
In December, 2019 in Wuhan, Hubei Province, China, a new, unknown strain of coronavirus called SARS-CoV-2 was identified. The virus has spread rapidly to other countries around the world, among which the most affected were Italy, Spain and the United States. As a result, in March 2020 The WHO has declared the new coronavirus epidemic a global pandemic. Despite timely measures and efforts to reduce morbidity, up to date, confirmed cases are 119,452,269, while the number of deaths reached 2,647,662 people. The COVID-19 pandemic has affected all areas of human life – health, social, economic. In each of them, a number of restrictions and obligations were imposed, including wearing of masks, use of disinfectants, education in an online environment, limited work in restaurants and shops. The health sector was particularly affected, and all actors in the pharmaceutical system had to reorganize and adapt their activities in the name of a common goal – ending the COVID-19 pandemic.
Type of Medium:
Online Resource
ISSN:
2603-557X
,
0428-0296
DOI:
10.3897/pharmacia.68.e71638
DOI:
10.3897/pharmacia.68.e71638.figure1
DOI:
10.3897/pharmacia.68.e71638.figure2
DOI:
10.3897/pharmacia.68.e71638.figure3
DOI:
10.3897/pharmacia.68.e71638.figure4
Language:
Unknown
Publisher:
Pensoft Publishers
Publication Date:
2021
detail.hit.zdb_id:
3010005-7
SSG:
15,3
Bookmarklink